News

OTC Markets Group Sees Record Dollar Volume Traded in 2024

OTC Markets Group Sees Record Dollar Volume Traded in 2024

OTC Markets Group Reports Impressive Trading Volume Growth

OTC Markets Group Inc. (OTCQX: OTCM) has revealed a monumental milestone in its operations with a remarkable total trading volume of $478.7 billion for the year 2024. This substantial figure marks an impressive year-over-year increase of around $95 billion from the previous year's volume of $383 billion.

Key Driver of Growth in 2024

The growth was widespread across various security types, with international securities trading hitting approximately $415 billion. This surge of around $92 billion compared to last year highlights the increasing interest from global investors, particularly due to streamlined access to the U.S. capital markets.

Q4 Trading Surge

The fourth quarter of 2024 demonstrated a notable uptick in trading activity when compared to the third quarter. This trend emphasizes the upward trajectory of OTC Markets Group's offerings, fueled by increased cross-trading opportunities.

Market Data Ecosystem’s Role

Matt Fuchs, Executive Vice President of Market Data at OTC Markets Group, pointed out that the growth reflects the global nature of equity trading and the efficiency of U.S. capital markets. "The structure we provide allows issuers and investors to interact in a cost-effective and data-driven manner. It’s a gateway to one of the world's largest pools of liquidity," he explained.

Year-on-Year Performance Highlights

Across all key categories of securities, the year-on-year performance has seen substantial boosts:

  • $415.57 billion in international securities, a remarkable $92.55 billion increase year on year.
  • $348.3 billion in American Depository Receipts (ADRs), with a $65.94 billion increase compared to the previous year.
  • $386.33 billion traded in securities with market caps exceeding $1 billion, reflecting a growth of $61.94 billion year over year.
  • $439.89 billion in non-penny stocks, showcasing an $87.37 billion rise.
  • $78.61 billion in SEC reporting securities, marking a modest increase of $3.46 billion.

Enhancing Market Experiences

This growth demonstrates the significance of market data ecosystems for global issuers seeking public liquidity without the traditional costs associated with conventional exchanges. OTC Markets Group is committed to aligning with the evolving needs of market participants, enhancing their trading experiences beyond current standards.

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets that facilitate the trading of over 12,000 U.S. and international securities. The company provides a foundation through data-driven disclosure standards across three distinct markets: OTCQX Best Market, OTCQB Venture Market, and Pink Open Market. Furthermore, their OTC Link Alternative Trading Systems (ATSs) provide essential market infrastructure for broker-dealers, ensuring efficient and effective trading capabilities.

Sign up for More Information

To understand how OTC Markets Group enhances informed and efficient trading, visit their main website.

Frequently Asked Questions

What is the total dollar volume traded by OTC Markets Group in 2024?

The total dollar volume traded reached $478.7 billion in 2024.

How much did the trading volume increase compared to the previous year?

The trading volume increased by approximately $95 billion from the previous year.

What types of securities saw significant growth?

International securities, ADRs, and non-penny stocks all displayed noteworthy increases in trading volumes.

What is the role of OTC Markets Group in capital markets?

OTC Markets Group provides a unique, data-driven trading environment for issuers and investors to access global liquidity.

How can I get more information about OTC Markets Group?

You can find detailed information by visiting the OTC Markets Group website to stay updated on their services and offerings.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Monitor Class Action Against Xerox Ahead of Deadline

Updated Category News Views 313

Xerox Holdings Corporation Under Legal Scrutiny Faruqi & Faruqi, LLP, a prominent national securities law firm, is reaching out to investors of Xerox Holdings Corporation (NASDAQ: XRX) to inform them about an ongoing class action lawsuit. Investors are reminded of an important deadline for those wanting to assume the role of lead plaintiff in this case. The deadline for...

Continue Reading
UBS's Caution on Dr. Reddy's Projections Signals Concerns

Updated Category News Views 155

UBS dropped a Sell rating on Dr. Reddy's Laboratories (NSE: DRRD) back in 2024, tagging the stock with a price target of INR 5,700.00. You could feel the tension shift in trading rooms as their assessment sparked fresh chatter about the firm’s US base business revenue projections that seem downright optimistic. UBS Questions Revenue Estimates: Too High or Just Right?...

Continue Reading
Evaluating Apple's Business Landscape Among Top Tech Firms

Updated Category News Views 115

Assessing Market Position and Performance In the dynamic world of technology hardware, it’s crucial for investors to analyze the competition thoroughly. This article takes a closer look at Apple (NASDAQ: AAPL) and compares its financial metrics and market position against its key competitors in the industry. With this analysis, we aim to provide insights into Apple's...

Continue Reading
Back to School: Parents Prepare for Illness and Solutions

Updated Category News Views 191

Back to School: Parents Brace for Sickness A recent survey shows that as children head back to the classroom, many parents anticipate facing a wave of illnesses at home. Conducted by Boiron, a leader in homeopathic remedies, this nationwide survey reveals parents' concerns about the inevitable germs that come along with the school year. Survey Insights on Parental...

Continue Reading
Scarf Systems Achieves SOC 2 Type 2 Examination Success

Updated Category News Views 72

Scarf Systems, Inc. completed a SOC 2 Type 2 examination back in early 2023, solidifying its place as a frontrunner in data security. This wasn't just some routine check; it was a deep dive into how well Scarf protected customer data and adhered to stringent safety protocols. But here’s the kicker—traders started asking: is this enough to keep investors calm? What’s...

Continue Reading